Financial statements Medianus Pharma
Cash flow statement of Medianus Pharma
Company age:
Age:
5 y. 10 m. 18 d.
Share capital:
Share capital:
100 000 PLN
Cash inflows of MEDIANUS PHARMA
|
Year
|
2019
|
|---|---|
| Net cash from operating expenses | -4 702,91 |
| Net cash flow from investing activities | -19 945,40 |
| Net cash flow from financial activities | 25 000,00 |
| Total net cash flow | 351,69 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.